Stay updated on TC-110 T Cells in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the TC-110 T Cells in Lymphoma Clinical Trial page.

Latest updates to the TC-110 T Cells in Lymphoma Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check7 days agoChange DetectedThe site’s footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedThe record history now includes a new site revision entry v3.7.0, added to the log. The previous revision v3.6.6 is removed as part of the update record.SummaryDifference0.1%

- Check50 days agoChange DetectedThe history now shows a new revision entry (v3.6.6) replacing the previous v3.6.5, indicating an internal update to the study record page.SummaryDifference0.1%

- Check71 days agoChange DetectedThe revision indicator on the page updated from v3.6.4 to v3.6.5, representing a new version of the record history interface.SummaryDifference0.1%

- Check85 days agoChange DetectedVersion 8 (Revision: v3.6.4) was returned on 2026-07-21, and the record now includes newly added sections for Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Study Status, with a Quality Control Review status of Has Not Concluded.SummaryDifference1%

Stay in the know with updates to TC-110 T Cells in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TC-110 T Cells in Lymphoma Clinical Trial page.